10th April 2013

Mirada Deformable Image Registration Selected for Advanced Radiation Therapy at The University Medical Centre Groningen – Netherlands

Mirada Medical and their innovative RTx and Workflow Box software tools have been selected by the University Medical Centre Groningen (UMCG),  The Netherlands, for use in the prestigious institution’s cancer treatment and research programs. UMCG is one of the largest hospitals in Europe and the Department of Radiation Oncology is recognised worldwide for their leading position in the area of prediction and prevention of normal tissue damage. UMCG intends to build a proton therapy facility that will be operational in 2017. “Achieving highly accurate deformable image registration for all patients and modalities was a top priority,” stated Professor Johannes Langendijk, M.D., Chair of Radiation Oncology at UMCG. “Mirada software fits seamlessly into our normal workflow and enables accurate registration, including for MRI and, critically, from on-board cone beam CT. Improved accuracy allows more precise contouring of disease, and dose delivery while minimising exposure to normal tissue,” continued Langendijk. Likewise, the auto-contouring tool for re-planning in RTx is accurate, quick and easy to use. “Our tests revealed the auto-contouring to be extremely accurate - closely matching our hand-drawn contours, even on the difficult cases,” added Langendijk. UMCG’s choice of Mirada Medical RTx software stemmed from the company’s leadership in Deformable Image Registration. The ability to precisely fuse and register complex data sets, including prior planning CTs, cone beam CT, PET/CT and MRI to the current planning CT, was critically important to UMCG for more accurately targeting RT while minimising exposure to normal tissue. This becomes even more important when UMCG starts treating patients with protons. After a thorough six month evaluation of available Deformable Image Registration software, UMCG selected Mirada’s suite of products based on the accuracy and robustness of Mirada’s registration algorithms especially in challenging cases. Mirada also uniquely registered MRI data, including all sequences, to the other modalities. “We are proud to have been selected by the prestigious University Medical Centre Groningen,” stated Dr. Timor Kadir, Chief Science and Technology Officer at Mirada Medical. “Deformable Image Registration is at the core of today’s advanced Radiation Therapy imaging workflows and we have developed our advanced registration algorithms to meet the high accuracy standards of prestigious cancer treatment centres like Groningen. And, we are excited about the future enhancements that will result from our on-going research and collaboration,” ended Kadir.